Ot Broadcast News

Multiple Myeloma: Big Survival Gains from Novel Agents 'in the Real World'

Informações:

Sinopse

Evangelos Terpos, speaking at the European Hematology Association 2010 Congress in Barcelona, discusses his group's encouraging findings based on 10 years of experience with thalidomide, lenalidomide, and bortezomib.